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Background
Risk stratification and early monitoring of anthracycline-
induced cardiotoxicity is crucial. It has been shown that
early histopathological changes occur well before
myocardial functional abnormalities can be detected.
Additionally a long period of latency with clinical recov-
ery of systolic function before the development of overt
heart failure has been described, further emphasizing
the importance of early recognition of cardiac injury
and defining routine follow-up.
Methods
Long-term childhood cancer survivors were prospec-
tively recruited after written informed consent. Study
protocol was approved by the institutional review board.
Subjects underwent a cardiovascular magnetic resonance
(CMR) study on a 1.5 Tesla scanner (Philips, Best,
Netherlands) with routine cine acquisition in long and
short axis planes, tissue characterization with native T1
mapping and late gadolinium enhancement (LGE),
selected 2D phase contrast flow imaging and 3D whole
heart anatomy. Ventricular volumes, mass, and ejection
fraction (EF) were obtained via standard planimetry
techniques using a semiautomated commercial software
(CMRtools, Imperial College, London, United Kingdom).
Myocardial and left atrial (LA) strain parameters were
derived from balanced SSFP cine images using dedicated
software (TomTec Imaging Systems, 2D CPA MR,
Cardiac Performance Analysis, Version 1.1.2.36, Unters-
chleissheim, Germany). LA reservoir, conduit and
contractile functions were then quantified by both frac-
tional volume changes and CMR feature tracking
derived strain and strain rate. Transit times for pulse
wave velocity (PWV) computations were determined
using the foot-to-foot methodology.
Results
Twenty patients (mean age 18 ± 2 years) were enrolled.
Twenty age-matched healthy controls (p = 0.109) were
also recruited for comparison. Patients were studied after
a mean anthracycline cumulative dose of 207 mg/m2,
83 months on average post-exposure. There was no sig-
nificant difference between both groups in terms of volu-
metric analysis (table 1), with both presenting no areas of
myocardial LGE. Left ventricular deformation parameters
(but not LA functional indices) such as global radial
strain (GRs) and strain rate (GRSr), global circumferen-
tial strain (GCs) and strain rate (GCSr), native T1 and
PWV were significantly different among the two groups
on both bivariate and multivariate regression analysis
(p < 0.001 to 0.035). GRSr (early diastole), GCSr (systole),
PWV and native T1 outperform other imaging biomar-
kers (figure 1) in the assessment of subtle myocardial and
vascular changes post-chemotherapy.
Conclusions
CMR can detect subtle myocardial and vascular
abnormalities in young cancer survivors with normal EF
exposed to anthracycline chemotherapy in the months
following exposure. CMR may provide the short term
markers of future cardiac morbidity necessary to design
safer treatment regimens for younger cancer survivors.
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Table 1 Baseline characteristics
CHARACTERISTICS PATIENTS CONTROLS p
Age, years 18 ± 2 [12-21] 19 ± 3 [12-24] 0.109
Gender, n 11 males; 9 females 12 males; 8 females 0.749
LV ejection fraction [LVEF (%)] 59 ± 3.5 61 ± 4.2 0.057
LV end-diastolic volume indexed [LVEDVi (mL/m2)] 85 ± 16.5 85 ± 14.1 0.975
LV end-systolic volume [LVESVi (mL/m2)] 35 ± 9.5 35 ± 9.1 0.946
Global circumferential strain (GCs) -14.0 ± 3.6 -16.4 ± 3.5 0.041
Global radial strain (GRs) 17.2 ± 6.4 30.7 ± 6.9 <0.001
Global circumferential strain rate [GCSr (syst)] -1.25 ± 0.26 -1.58 ± 0.41 0.005
Global radial strain rate peak systole [GCRSr (syst)] 0.86 ± 0.21 2.44 ± 0.5 <0.001
Global circumferential strain rate early diastole [GCSr (diast)] 1.49 ± 0.41 1.85 ± 0.52 0.022
Global radial strain rate early diastole [GRSr (diast)] -1.61 ± 0.38 -2.21 ± 0.61 0.001
Native T1 (mid septum, ms) 1004 ± 70.6 966 ± 30.6 0.035
LA ejection fraction total (%) 66.9 ± 8.3 67.9 ± 7.8 0.692
LA conduit function (%) 41.2 ± 15.1 41.5 ± 10.6 0.928
LA booster pump function (%) 42.3 ± 9.1 44.5 ± 10.8 0.682
LA total strain (εs) 30.6 ± 8.6 30.7 ± 7.4 0.967
LA passive strain (εe) 24.1 ± 6.4 23.3 ± 5.2 0.638
LA active strain (εa) 6.5 ± 3.5 7.5 ± 3.6 0.400
LA peak positive strain rate (SRs) 1.2 ± 0.3 1.3 ± 0.4 0.430
LA peak early negative strain rate (SRe) -1.7 ± 0.4 1.7 ± 0.4 0.941
LA peak late negative strain rate (SRa) -0.9 ± 0.3 -1.0 ± 0.3 0.148
Pulse wave velocity [PWV (m/s)] 4.605 ± 0.51 3.742 ± 0.23 0.019
Figure 1 Panel 1 (A to F) depicts the PWV, T1 mapping/myocardial fibrosis analysis, LA and LV indices assessed. ROC curve (Panel 2)
comparing the sensitivity and specificity of different imaging biomarkers analyzed and chemotherapy treatment.
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